The HIT-Institute is dedicated to increase global health information analysis capabilities and assisting individuals seeking medical care. The HIT-Institute is dedicated to increase global health information analysis capabilities and assisting underserved individuals seeking medical care to receive quality medical care. The HIT-Institute also provides public and private sector institutions develop emergency medical plans and provisioning for natural disasters, man-made disasters and pandemic syndromes. The HIT-Institute has advanced understanding based on a Cooperative Research and Development Agreement (CRADA) between the U.S. FDA Centers for Drug Evaluation and Research and a non-profit DataPharm Foundation that was reassigned to the HIT-Institute for electronic labeling registration.